Sana Biotechnology (SANA) Announces CFO Resignation

On September 6, 2024, Nathan Hardy notified Sana Biotechnology (NASDAQ: SANA) that he intends to resign from his position as Executive Vice President and Chief Financial Officer of the Company effective October 4, 2024. Mr. Hardy resigned voluntarily for personal reasons and not as a result of any disagreement with the Company on any matter, including related to the Company’s operations, policies, practices or otherwise.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• DraftKings replaces BDO with Deloitte as its auditor for fiscal 2027
• KKR reports over $750M in Q3 monetization activity